Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evaxion A (EVAX) Debt Ratio (2021 - 2025)

Evaxion A posted quarterly Debt Ratio of 0.19 for Q4 2025, down 70.2% year-on-year from 0.65 in Q4 2024, and down 52.52% on a QoQ basis from 0.41 in Q2 2025.

Evaxion A (EVAX) has 5 years of Debt Ratio data on file, last reported at 0.19 in Q4 2025.

  • For the quarter ending Q4 2025, Debt Ratio fell 70.2% year-over-year to 0.19; the trailing twelve-month figure through Dec 2025 stood at 0.19 (down 70.2% YoY), and the FY2025 full-year result was 0.19, down 70.2% from the prior year.
  • Debt Ratio for Q4 2025 stood at 0.19, down from 0.41 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.67 in Q4 2023 and bottomed at 0.03 in Q4 2021.
  • The 5-year median for Debt Ratio is 0.36 (2022), against an average of 0.35.
  • The widest annual swing landed in 2022, when Debt Ratio surged 1146.85%; it then tumbled 70.2% in 2025.
  • A 5-year view of Debt Ratio shows it stood at 0.03 in 2021, then soared by 1146.85% to 0.36 in 2022, then surged by 84.72% to 0.67 in 2023, then declined by 2.51% to 0.65 in 2024, then sank by 70.2% to 0.19 in 2025.
  • The last three Debt Ratio figures came in at 0.19 (Q4 2025), 0.41 (Q2 2025), and 0.65 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.18
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 1.41
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.05
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.19
Jun 30, 2025 0.41
Dec 31, 2024 0.65
Jun 30, 2024 0.55
Dec 31, 2023 0.67
Jun 30, 2023 0.49
Dec 31, 2022 0.36
Jun 30, 2022 0.22
Mar 31, 2022 0.19
Dec 31, 2021 0.03
Sep 30, 2021 0.05